Cool new technology that holds promise for asthma and other antigen-driven allergic conditions!
pubmed.ncbi.nlm.nih.gov/40985871/
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice - PubMed
Allergic diseases have reached epidemic proportions globally, calling attention to the need for better treatment and preventive approaches. Herein, we developed allergen-encoding messenger RNA (mRNA)-lipid nanoparticle (LNP) strategies for both therapy and prevention of allergic responses. Immunizat …
